TY  - GEN
AU  - Florescu,Marie
AU  - Hasan,Baktiar
AU  - Seymour,Lesley
AU  - Ding,Keyue
AU  - Shepherd,Frances A
TI  - A clinical prognostic index for patients treated with erlotinib in National Cancer Institute of Canada Clinical Trials Group study BR.21
SN  - 1556-1380
PY  - 2008///0807
KW  - Carcinoma, Non-Small-Cell Lung
KW  - drug therapy
KW  - Dose-Response Relationship, Drug
KW  - ErbB Receptors
KW  - antagonists & inhibitors
KW  - Erlotinib Hydrochloride
KW  - Female
KW  - Follow-Up Studies
KW  - Humans
KW  - Lung Neoplasms
KW  - Male
KW  - Middle Aged
KW  - Neoplasm Staging
KW  - Ontario
KW  - epidemiology
KW  - Prognosis
KW  - Proportional Hazards Models
KW  - Protein Kinase Inhibitors
KW  - administration & dosage
KW  - Quinazolines
KW  - Survival Rate
KW  - Time Factors
N1  - Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial
UR  - https://doi.org/10.1097/JTO.0b013e3181729299
ER  -